What’s New
- Talzenna Plus Xtandi May Improve Survival in Metastatic Castration-Resistant Prostate Cancer
- BRCA1 Contribution to Prostate Cancer Called Into Question
- Hydroablation Device Shows Promise for Early Prostate Cancer
- Prognostic Value of MR Visibility/Invisibility in Men on Active Surveillance
- Highlights of the 31st Annual PCF Scientific Retreat